April 17, 2025

iPSC-Derived Cells Show Promise for Parkinson's

A phase I/II trial demonstrated that allogeneic iPSC-derived dopaminergic progenitors survived, produced dopamine, and did not form tumors.

Conexiant

April 17, 2025

Phase 3 Trial Supports New Gonorrhea Drug

Trial shows oral gepotidacin is non-inferior to ceftriaxone plus azithromycin for treating uncomplicated urogenital gonorrhea.

Conexiant

April 17, 2025

Fermented Cabbage Preserves Gut Barrier Integrity

"Fermented cabbage, but not raw cabbage or brine, protected against cytokine-induced damage to the Caco-2 monolayers," reveals new research on how sauerkraut's metabolites may benefit intestinal health.

Conexiant

April 17, 2025

Early Ezetimibe After MI Tied to Reduced MACE in SWEDEHEART Registry

Delaying ezetimibe use after MI was associated with worse outcomes in a Swedish national cohort study of 35,826 patients.

Conexiant

April 17, 2025

Diet, WHR Linked to Late-Life Brain Connectivity

"These findings suggest that interventions to improve diet and manage central obesity might be best targeted in middle to older age," concludes the Whitehall II cohort study showing how midlife metrics correlate with hippocampal connectivity and cognitive function at age 70.

Conexiant

April 17, 2025

Eyebrows Signal Understanding Gaps in Conversation

Eyebrow furrows can silently signal 'I've not received enough information,' researchers found, as these facial cues influenced the likelihood and type of verbal repair in conversation.

Conexiant

April 16, 2025

Germline Variants May Impact Unique Nature of a Patient’s Cancer, Study Shows

Research into germline genetic variants has identified ways that an individual’s genetic makeup can shape the biology of their cancer. The report, published in Cell, shows how these findings could pot...

The ASCO Post

April 16, 2025

How Do Feet Beat the Stress?

"As the calcaneus grows in size, it becomes taller, wider, and relatively shorter—essentially, more cube-like—revealing nature’s quiet strategy to manage internal bone stress."

Conexiant

April 16, 2025

Newer Glucose-Lowering Drugs Reduce CV Events in Older Adults

"Use of GLP1-RAs and SGLT-2is was associated with reduced rates of 3P-MACE and HHF compared to DPP-4is, independent of age" - findings from a Danish nationwide study of 35,679 patients aged 70 and older with T2D.

Conexiant